Transgene Biotek Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 0.05 | 0.05 | 0.12 |
| Operating Expense | 0.13 | 0.19 | 0.62 |
| Net Profit | -0.39 | -0.43 | -0.71 |
| Net Profit Margin | -780 | -860 | -591.67 |
| Earning Per Share | -0.05 | -0.06 | -0.09 |
| EBIDTA | -0.08 | -0.13 | -0.50 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 0.05 |
| Operating Expense | 0.13 |
| Net Profit | -0.39 |
| Net Profit Margin | -780.00 |
| Earning Per Share | -0.05 |
| EBIDTA | -0.08 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 0.26 | 0.23 | 0.06 |
| Operating Expenses Annual | 1.38 | 0.85 | 1.11 |
| Operating Profit Annual | -0.34 | -0.43 | -0.88 |
| Interest Annual | 0.24 | 0.13 | 0.18 |
| Depreciation | 0.09 | 0.09 | 0.09 |
| Net Profit Annual | -0.68 | -0.66 | -6.01 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 0.26 |
| Operating Expenses Annual | 1.38 |
| Operating Profit Annual | -0.34 |
| Interest Annual | 0.24 |
| Depreciation | 0.09 |
| Net Profit Annual | -0.68 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.01 | TBA | 0.02 |
| Cash Flow from Operations | 1.20 | TBA | TBA |
| Cash Flow from Investing | -1.70 | TBA | -0.01 |
| Cash Flow from Financing | 0.78 | TBA | TBA |
| Cash Flow at the End | 0.28 | 0.01 | TBA |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.01 |
| Cash Flow from Operations | 1.20 |
| Cash Flow from Investing | -1.70 |
| Cash Flow from Financing | 0.78 |
| Cash Flow at the End | 0.28 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -130.77 | -182.61 | -733.33 |
| PBIT Margin (%) | -165.38 | -221.74 | -8,983.33 |
| PBT Margin (%) | 538.47 | 1,391.30 | 5,500.00 |
| Net PROFIT Margin (%) | -261.54 | -286.96 | -10,016.67 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -2.62 | -2.87 | TBA |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.01 | 0.01 | TBA |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -130.77 |
| PBIT Margin (%) | -165.38 |
| PBT Margin (%) | 538.47 |
| Net PROFIT Margin (%) | -261.54 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -2.62 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 9.83 | 8.22 | 8.32 |
| Total Current Assets Annual | 1.26 | 1.10 | 1.04 |
| Non Current Assets Annual | 32.95 | 31.34 | 31.44 |
| Total Shareholders Funds Annual | -7.55 | -6.87 | -6.21 |
| Total Assets Annual | 34.20 | 32.44 | 32.48 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 9.83 |
| Total Current Assets Annual | 1.26 |
| Non Current Assets Annual | 32.95 |
| Total Shareholders Funds Annual | -7.55 |
| Total Assets Annual | 34.20 |
EPS (INR)
Expected
0.00
Reported
-0.05
Surprise
0.00%
Jun 2025
EPS beaten by 0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
